SUN08 Pearls: Medical Dermatology
DESCRIPTION
Medical pearls for dermatologists are actually shared experiences. Pearls and tips originate from experiences in clinic, in research, and even in relationships with patients, and the pearls of what not to do are often more salient than those of what to do. This session will bring a variety of pearls that will optimize patient outcomes and safety, while exploring the myths, misconceptions, and realities of comfort level of dermatologists for optimizing systemic therapies. The themes of “don’t be afraid” and the costs of not treating patients compared to costs to the system will be explored.
LEARNING OBJECTIVES
Apply the mechanisms of therapy to the mechanisms of disease to counter the process and not just the immediate presentation.
Develop opportunities for expanding treatment algorithms based on long-term safety and FDA approvals based on research data.
Compare and formulate the costs of not treating patients aggressively to the perceived costs to the system of therapies that are effective in dermatology.
SCHEDULE
1:00 PM
Michelle's Marvelous Medical Pearls
Michelle B. Tarbox, MD, FAAD
1:10 PM
Neal's No Nonsense Medical Pearls
Neal D. Bhatia, MD, FAAD
1:20 PM
Q&A and More Pearls
1:30 PM
Adjourn
SPEAKERS
Neal D. Bhatia, MD, FAAD
Therapeutics Clinical Research, San Diego, California
Michelle B. Tarbox, MD, FAAD
Texas Tech University Health Science Center Department of Dermatology
HANDOUTS
SPEAKER DISCLOSURES
Neal D. Bhatia, MD, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria); Aclaris Therapeutics, Inc. – Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Alumis – Investigator(Grants/Research Funding); Apogee Therapeutics – Investigator(Grants/Research Funding); Arcutis, Inc. – Investigator(Grants/Research Funding); Beiersdorf, Inc. – Consultant(Honoraria); Biofrontera AG – Consultant(Honoraria); BMS – Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim – Investigator(Grants/Research Funding); Botanix Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); Castle Biosciences – Consultant(Honoraria); Dermeleve – Consultant (1099 relationship)(Honoraria); Galderma Laboratories, L.P. – Consultant(Honoraria); Johnson and Johnson Consumer Products Company – Investigator(Honoraria); La Roche-Posay Laboratorie Pharmaceutique – Consultant(Honoraria); LEO Pharma, US – Investigator(Grants/Research Funding); Mindera – Investigator(Grants/Research Funding); Nutrafol – Investigator(Grants/Research Funding); Ortho Dermatologics – Consultant(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Practical Dermatology – Other(Honoraria); Sanofi/Regeneron – Consultant(Honoraria), Investigator(Grants/Research Funding); Soligenix, Inc – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Consultant(Honoraria), Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Investigator(Grants/Research Funding); Zerigo Health – Investigator(Grants/Research Funding);
Michelle B. Tarbox, MD, FAAD
Boehringer Ingelheim – Advisory Board(Honoraria); Castle Biosciences – Investigator(Grants/Research Funding); Dermaleve – Advisory Board(Honoraria); Galderma – Speaker(Honoraria); Novartis – Advisory Board(Honoraria); Sanofi/Regeneron – Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria);